Balance Sheet of Perk Pharmaceuticals

------------------- in Rs. Cr. ------------------Mar

'11

Mar '10

Mar '09

Mar '08

12
mths

12 mths

12 mths

12 mths

12

6.38
6.38
0.00
0.00

6.38
6.38
0.00
0.00

6.38
6.38
0.00
0.00

-0.80

-1.13

-1.15

0.00
5.58

0.00
5.25

0.00
5.23

0.27
0.00
0.27
5.85

0.33
0.00
0.33
5.58

0.46
0.00
0.46
5.69

Mar '10

Mar '09

Mar '08

12
mths

12 mths

12 mths

12 mths

12

Gross Block
Less: Accum. Depreciation
Net Block

4.06
0.14
3.92

4.12
0.14
3.98

6.14
2.02
4.12

6.14
1.87
4.27

Capital Work in Progress

Investments

0.00
0.00

0.00
0.00

0.00
0.00

0.00
0.00

Inventories
Sundry Debtors
Cash and Bank Balance
Total Current Assets
Loans and Advances
Fixed Deposits
Total CA, Loans & Advances
Deffered Credit
Current Liabilities
Provisions
Total CL & Provisions
Net Current Assets

0.61
1.95
0.32
2.88
0.29
0.00
3.17
0.00
1.39
0.01
1.40
1.77

0.68
1.67
0.06
2.41
0.31
0.00
2.72
0.00
0.84
0.01
0.85
1.87

0.70
0.86
0.07
1.63
0.25
0.00
1.88
0.00
0.41
0.01
0.42
1.46

0.93
0.60
0.28
1.81
0.45
0.00
2.26
0.00
0.85
0.01
0.86
1.40

Miscellaneous Expenses
Total Assets

0.00
5.69

0.00
5.85

0.00
5.58

0.02
5.69

Contingent Liabilities
Book Value (Rs)

0.00
8.87

0.00
8.75

0.00
8.24

0.00
8.20

Sources Of Funds
Total Share Capital
Equity Share Capital
Share Application Money
Preference Share Capital
Reserves
Revaluation Reserves
Networth
Secured Loans
Unsecured Loans
Total Debt
Total Liabilities

6.38
6.38
0.00
0.00
0.72
0.00
5.66
0.02
0.00
0.02
5.68
Mar
'11

Application Of Funds

Profit & Loss account of Perk Pharmaceuticals

------------------- in Rs. Cr. ------------------Mar

'11

Mar '10

Mar '09

Mar '08

12
mths

12 mths

12 mths

12 mths

12

1.21
0.00
1.21
0.00
-0.07
1.14

1.32
0.00
1.32
0.00
-0.02
1.30

1.36
0.00
1.36
0.00
0.14
1.50

1.30
0.00
1.30
0.01
-0.05
1.26

0.34
0.02
0.07
0.07
0.00
0.42
0.00
0.92
Mar
'11

0.33
0.02
0.04
0.06
0.00
0.37
0.00
0.82

0.75
0.03
0.11
0.00
0.00
0.44
0.00
1.33

0.84
0.03
0.15
0.00
0.03
0.36
0.00
1.41

Mar '10

Mar '09

Mar '08

12
mths

12 mths

12 mths

12 mths

12

Operating Profit

0.22

0.48

0.17

-0.16

PBDIT
Interest
PBDT
Depreciation
Other Written Off
Profit Before Tax
Extra-ordinary items
PBT (Post Extra-ord Items)
Tax
Reported Net Profit

0.22
0.00
0.22
0.14
0.00
0.08
0.00
0.08
0.00
0.07

0.48
0.00
0.48
0.14
0.00
0.34
0.00
0.34
0.00
0.33

0.17
0.00
0.17
0.15
0.00
0.02
0.00
0.02
0.00
0.02

-0.15
0.00
-0.15
0.16
0.00
-0.31
0.00
-0.31
0.00
-0.30

Total Value Addition

Preference Dividend
Equity Dividend
Corporate Dividend Tax
Per share data (annualised)

0.58
0.00
0.00
0.00

0.50
0.00
0.00
0.00

0.58
0.00
0.00
0.00

0.57
0.00
0.00
0.00

63.84
0.12

63.84
0.52

63.84
0.04

63.84
-0.48

0.00
8.87

0.00
8.75

0.00
8.24

0.00
8.20

Income
Sales Turnover
Excise Duty
Net Sales
Other Income
Stock Adjustments
Total Income
Expenditure
Raw Materials
Power & Fuel Cost
Employee Cost
Other Manufacturing Expenses
Selling and Admin Expenses
Miscellaneous Expenses
Preoperative Exp Capitalised
Total Expenses

Shares in issue (lakhs)

Earning Per Share (Rs)
Equity Dividend (%)
Book Value (Rs)

Cash Flow of Perk Pharmaceuticals

------------------- in Rs. Cr. ------------------Mar '11

Mar '10

Mar '09

Mar '08

12 mths

12 mths

12 mths

12 mths

12

Net Profit Before Tax

0.07

0.33

0.02

-0.30

Net Cash From Operating Activities

Net Cash (used in)/from
Investing Activities
Net Cash (used in)/from Financing Activities
Net (decrease)/increase In Cash and Cash
Equivalents

0.58

0.05

-0.08

0.03

-0.08

0.00

0.00

0.04

-0.25

-0.05

-0.13

0.11

0.25

-0.01

-0.21

0.17

0.06
0.32

0.07
0.06

0.28
0.07

0.11
0.28

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalents

Key Financial Ratios of Perk Pharmaceuticals

Mar
'11

Mar '10

Mar '09

Mar '08

Face Value
Dividend Per Share
Operating Profit Per Share (Rs)
Net Operating Profit Per Share (Rs)
Free Reserves Per Share (Rs)
Bonus in Equity Capital
Profitability Ratios

10.00
-0.34
1.90
---

10.00
-0.74
2.07
---

10.00
-0.28
2.14
---

10.00
--0.23
2.04
-0.03
--

Operating Profit Margin(%)

Profit Before Interest And Tax Margin(%)
Gross Profit Margin(%)
Cash Profit Margin(%)
Adjusted Cash Margin(%)
Net Profit Margin(%)
Adjusted Net Profit Margin(%)
Return On Capital Employed(%)
Return On Net Worth(%)
Adjusted Return on Net Worth(%)
Return on Assets Excluding Revaluations
Return on Assets Including Revaluations
Return on Long Term Funds(%)
Liquidity And Solvency Ratios

18.02
6.37
6.37
17.82
17.82
6.17
6.17
1.36
1.32
1.32
8.87
8.87
1.36

----35.74
24.89
---5.88
8.75
8.75
5.60

----12.88
1.81
---0.47
8.24
8.24
0.44

-----11.05
-23.21
----5.82
8.17
8.17
-5.33

2.26
1.83
---

3.22
2.42
0.05
0.05

4.50
2.83
0.06
0.06

2.64
1.55
0.09
0.09

31.70
0.00
89.66
89.66

-0.05
---

-0.06
---

-0.09
---

2.00
0.67
2.00
0.30
0.21
0.30

-1.04
1.95
--0.32

-1.86
1.95
--0.22

-2.28
1.40
--0.21

--524.40

--512.81

--386.54

--386.41

28.18
----

24.77
----

55.06
----

64.24
-1.99
--

Investment Valuation Ratios

Current Ratio
Quick Ratio
Debt Equity Ratio
Long Term Debt Equity Ratio
Debt Coverage Ratios
Interest Cover
Total Debt to Owners Fund
Financial Charges Coverage Ratio
Financial Charges Coverage Ratio Post Tax
Management Efficiency Ratios
Inventory Turnover Ratio
Debtors Turnover Ratio
Investments Turnover Ratio
Fixed Assets Turnover Ratio
Total Assets Turnover Ratio
Asset Turnover Ratio
Average Raw Material Holding
Average Finished Goods Held
Number of Days In Working Capital
Profit & Loss Account Ratios
Material Cost Composition
Imported Composition of Raw Materials Consumed
Selling Distribution Cost Composition
Expenses as Composition of Total Sales

Cash Flow Indicator Ratios

Dividend Payout Ratio Net Profit
Dividend Payout Ratio Cash Profit
Earning Retention Ratio
Cash Earning Retention Ratio
AdjustedCash Flow Times

Earnings Per Share

Book Value

--100.00
100.00
0.10

--100.00
100.00
0.58

--100.00
100.00
1.88

------

Mar
'11

Mar '10

Mar '09

Mar '08

0.12
8.87

0.52
8.75

0.04
8.24

-0.48
8.20

1
1